Obestatin regulates adipocyte function and protects against diet‐induced insulin resistance and inflammation
Open Access
- 17 May 2012
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 26 (8) , 3393-3411
Abstract
The metabolic actions of the ghrelin gene‐derived peptide obestatin are still unclear. We investigated obestatin effects in vitro , on adipocyte function, and in vivo , on insulin resistance and inflammation in mice fed a high‐fat diet (HFD). Obestatin effects on apoptosis, differentiation, lipolysis, and glucose uptake were determined in vitro in mouse 3T3‐L1 and in human subcutaneous (hSC) and omental (hOM) adipocytes. In vivo , the influence of obestatin on glucose metabolism was assessed in mice fed an HFD for 8 wk. 3T3‐L1, hSC, and hOM preadipocytes and adipocytes secreted obestatin and showed specific binding for the hormone. Obestatin prevented apoptosis in 3T3‐L1 preadipocytes by increasing phosphoinositide 3‐kinase (PI3K)/Akt and extracellular signal‐regulated kinase (ERK)1/2 signaling. In both mice and human adipocytes, obestatin inhibited isoproterenol‐induced lipolysis, promoted AMP‐activated protein kinase phosphorylation, induced adiponectin, and reduced leptin secretion. Obestatin also enhanced glucose uptake in either the absence or presence of insulin, promoted GLUT4 translocation, and increased Akt phosphorylation and sirtuin 1 (SIRT1) protein expression. Inhibition of SIRT1 by small interfering RNA reduced obestatin‐induced glucose uptake. In HFD‐fed mice, obestatin reduced insulin resistance, increased insulin secretion from pancreatic islets, and reduced adipocyte apoptosis and inflammation in metabolic tissues. These results provide evidence of a novel role for obestatin in adipocyte function and glucose metabolism and suggest potential therapeutic perspectives in insulin resistance and metabolic dysfunctions.—Granata, R., Gallo, D., Luque, R. M., Baragli, A., Scarlatti, F., Grande, C., Gesmundo, I., Córdoba‐Chacón, J., Bergandi, L., Settanni, F., Togliatto, G., Volante, M., Garetto, S., Annunziata, M., Chanclón, B., Gargantini, E., Rocchietto, S., Matera, L., Datta, G., Morino, M., Brizzi, M. F., Ong, H., Camussi, G., Castaño, J. P., Papotti, M., Ghigo, E. Obestatin regulates adipocyte function and protects against diet‐induced insulin resistance and inflammation. FASEB J. 26, 3393–3411 (2012). www.fasebj.orgKeywords
Funding Information
- Regione Piemonte
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Compagnia di San Paolo
- Instituto de Salud Carlos III (FI06/00804, BFU2010-19300, CTS-5051)
- Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición
- Instituto de Salud Carlos III
This publication has 60 references indexed in Scilit:
- Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Insulin sensitivity: modulation by nutrients and inflammationJournal of Clinical Investigation, 2008
- Obestatin Induction of Early-Response Gene Expression in Gastrointestinal and Adipose Tissues and the Mediatory Role of G Protein-Coupled Receptor, GPR39Molecular Endocrinology, 2008
- Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious ratsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Comment on "Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food Intake"Science, 2007
- Normal Food Intake and Body Weight in Mice Lacking the G Protein-Coupled Receptor GPR39Endocrinology, 2007
- GPR39 Signaling Is Stimulated by Zinc Ions But Not by ObestatinEndocrinology, 2007
- Inflammation and metabolic disordersNature, 2006
- Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food IntakeScience, 2005
- Adipose Tissue as an Endocrine OrganTrends in Endocrinology & Metabolism, 2000